Immunotherapy May Be Efficacious in Patients With HIV-associated Kaposi's Sarcoma
September 07, 2018
September 07, 2018
PHILADELPHIA, Pennsylvania, Sept. 7 -- The American Association for Cancer Research issued the following news release:
Among a small cohort of patients with HIV-associated Kaposi's sarcoma treated with immune checkpoint inhibitors, more than 65 percent had partial or complete remission, according to results published in Cancer Immunology Research (http://cancerimmunolres.aacrjournals.org/), a journal of the American Association for Cancer Research.
"Despite the suc . . .
Among a small cohort of patients with HIV-associated Kaposi's sarcoma treated with immune checkpoint inhibitors, more than 65 percent had partial or complete remission, according to results published in Cancer Immunology Research (http://cancerimmunolres.aacrjournals.org/), a journal of the American Association for Cancer Research.
"Despite the suc . . .